SLC31A1 and metastatic malignant neoplasm in the lymph nodes: Elevated serum SLC31A1 levels were significantly associated with poor prognosis, advanced TNM stages (III/IV), poor differentiation, thyroid exocapsular invasion, and lymph node metastasis.